BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 226 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $566,000 | -58.8% | 3,881 | -66.5% | 0.00% | 0.0% |
| Q1 2022 | $1,373,000 | -58.5% | 11,580 | -70.0% | 0.00% | -83.3% |
| Q4 2020 | $3,307,000 | +369.7% | 38,581 | +256.3% | 0.01% | +200.0% |
| Q3 2020 | $704,000 | +4.9% | 10,829 | +18.0% | 0.00% | -33.3% |
| Q2 2020 | $671,000 | +57.5% | 9,180 | -26.7% | 0.00% | 0.0% |
| Q1 2020 | $426,000 | -85.6% | 12,529 | -77.0% | 0.00% | -85.0% |
| Q4 2019 | $2,967,000 | -19.6% | 54,504 | -38.4% | 0.02% | -33.3% |
| Q3 2019 | $3,689,000 | -18.1% | 88,421 | -14.0% | 0.03% | -26.8% |
| Q2 2019 | $4,504,000 | +6937.5% | 102,847 | +5942.7% | 0.04% | +4000.0% |
| Q3 2018 | $64,000 | -67.0% | 1,702 | -65.3% | 0.00% | -50.0% |
| Q2 2018 | $194,000 | -88.7% | 4,904 | -92.6% | 0.00% | -88.2% |
| Q1 2018 | $1,713,000 | – | 66,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |